Atherosclerotic risk factors and carotid stiffness in elderly asymptomatic HD patients

Paraskevi Tseke1, Eirini Grapsa, Kimon Stamatelopoulos

  • 1Renal Unit, General Hospital Alexandra, University of Athens, Alexandroupoleos 48, 115 27, Athens, Greece. tsekedaki@hotmail.com

Insights

Carotid atherosclerosis and stiffness are common in elderly hemodialysis patients, linked to inflammation, metabolic issues, and obesity. Monitoring these factors may help prevent cardiovascular events in this high-risk group.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Vascular Biology

Background:

  • Carotid atherosclerosis and stiffness are established cardiovascular risk factors.
  • Their impact on non-diabetic elderly hemodialysis patients without prior cardiovascular disease is not fully understood.

Purpose of the Study:

  • To investigate the effect of established and potential risk factors on carotid atherosclerosis and stiffness in elderly, non-diabetic hemodialysis patients.

Main Methods:

  • B-mode ultrasonography assessed carotid intima-media thickness and plaques.
  • Carotid elasticity measured via compliance, distensibility, and elastic modulus.
  • Systemic arterial stiffness assessed using augmentation index from radial artery tonometry.

Main Results:

  • Carotid plaques (76%) and wall thickening (73.3%) were frequent, associated with fibrinogen, diastolic blood pressure, visceral obesity, and intact parathyroid hormone (i-PTH).
  • Systemic and carotid stiffness correlated with hs-CRP, serum ferritin, age, lipids, and i-PTH.

Conclusions:

  • Elderly hemodialysis patients exhibit high rates of carotid stiffening and atherosclerosis.
  • These conditions are linked to hemodynamic factors, inflammation, metabolic dysfunction, and obesity, highlighting the need for monitoring to prevent cardiovascular events.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...